UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

American journal of physiology. Regulatory, integrative and comparative physiology, 2003-02, Vol.284 (2), p.345-R353

2003

Volltextzugriff (PDF)

Anxiolytic- and Antidepressant-like Effects of the Non-Peptide Vasopressin V1b Receptor Antagonist, SSR149415, Suggest an Innovative Approach for the Treatment of Stress-Related Disorders

Proceedings of the National Academy of Sciences - PNAS, 2002-04, Vol.99 (9), p.6370-6375

2002

Volltextzugriff (PDF)

Cannabinoids Modulate Synaptic Strength and Plasticity at Glutamatergic Synapses of Rat Prefrontal Cortex Pyramidal Neurons

Journal of neurophysiology, 2000-06, Vol.83 (6), p.3287-3293

2000

Volltextzugriff (PDF)

Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells

The Journal of physiology, 1998-08, Vol.510 (3), p.867-879

1998

Volltextzugriff (PDF)

Nicotine-Associated Cues Maintain Nicotine-Seeking Behavior in Rats Several Weeks after Nicotine Withdrawal: Reversal by the Cannabinoid (CB ) Receptor Antagonist, Rimonabant (SR141716)

Neuropsychopharmacology (New York, N.Y.), 2005-01, Vol.30 (1), p.145-155

2005

Volltextzugriff (PDF)

SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair

The Journal of pharmacology and experimental therapeutics, 2002-06, Vol.301 (3), p.1067-1078

2002

Volltextzugriff (PDF)

Rimonabant reduces obesity‐associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

Hepatology (Baltimore, Md.), 2007-07, Vol.46 (1), p.122-129

2007

Volltextzugriff (PDF)

CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance

The FASEB journal, 2005-09, Vol.19 (11), p.1567-1569

2005

Volltextzugriff (PDF)

Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice

Neuroscience letters, 2003-06, Vol.343 (3), p.216-218

2003

Volltextzugriff (PDF)

Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells

European journal of pharmacology, 1998-11, Vol.360 (2-3), p.265-272

1998

Volltextzugriff (PDF)

Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress-related disorders

Current pharmaceutical design, 2005-05, Vol.11 (12), p.1549-1559

2005

Volltextzugriff (PDF)

Biochemical and Pharmacological Profile of a Potent and Selective Nonpeptide Antagonist of the Neurotensin Receptor

Proceedings of the National Academy of Sciences - PNAS, 1993-01, Vol.90 (1), p.65-69

1993

Volltextzugriff (PDF)

The Striatal Neurotensin Receptor Modulates Striatal and Pallidal Glutamate and GABA Release: Functional Evidence for a Pallidal Glutamate-GABA Interaction via the Pallidal-Subthalamic Nucleus Loop

The Journal of neuroscience, 1998-09, Vol.18 (17), p.6977-6989

1998

Volltextzugriff (PDF)

Facilitation by Endogenous Tachykinins of the NMDA-Evoked Release of Acetylcholine after Acute and Chronic Suppression of Dopaminergic Transmission in the Matrix of the Rat Striatum

The Journal of neuroscience, 2002-03, Vol.22 (5), p.1929-1936

2002

Volltextzugriff (PDF)

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors

Psychopharmacologia, 1997-07, Vol.132 (1), p.104-106

1997

Volltextzugriff (PDF)

Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia

Brain research, 2002-10, Vol.953 (1), p.63-72

2002

Volltextzugriff (PDF)

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

FEBS letters, 1994-08, Vol.350 (2), p.240-244

1994

Volltextzugriff (PDF)

Blockade by the cannabinoid CBI receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior

Neuropsychopharmacology (New York, N.Y.), 2004-05, Vol.29 (5), p.911-920

2004

Volltextzugriff (PDF)

Reconciling the role of central serotonin neurons in human and animal behavior

The Behavioral and brain sciences, 1986-06, Vol.9 (2), p.319-335

Soubrié, Philippe

1986

Volltextzugriff (PDF)

Characterization of the profile of neurokinin-2 and neurotensin receptor antagonists in the mouse defense test battery

Neuroscience and biobehavioral reviews, 2001-12, Vol.25 (7-8), p.619-626

2001

Volltextzugriff (PDF)

In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist

European journal of pharmacology, 1993-12, Vol.250 (3), p.403-413

1993

Volltextzugriff (PDF)

Specific involvement of neurotensin type 1 receptor in the neurotensin‐mediated in vivo dopamine efflux using knock‐out mice

Journal of neurochemistry, 2004-04, Vol.89 (1), p.1-6

2004

Volltextzugriff (PDF)

EFFECTS OF CB1 CANNABINOID RECEPTOR BLOCKADE ON ETHANOL PREFERENCE AFTER CHRONIC ALCOHOL ADMINISTRATION COMBINED WITH REPEATED RE-EXPOSURES AND WITHDRAWALS

Alcohol and alcoholism (Oxford), 2004-11, Vol.39 (6), p.486-492

2004

Volltextzugriff (PDF)

1 – 25 von 140

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135)
Mit Volltextzugriff
(112)

Publikationsform

Artikel
(139)
Buchkapitel
(1)

Sprache

Englisch
(140)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Animals
(96)
Science & Technology
(96)
Life Sciences & Biomedicine
(92)
Male
(75)
Rats
(71)
Biological And Medical Sciences
(60)
Pharmacology & Pharmacy
(53)
Neurosciences
(49)
Neurosciences & Neurology
(49)
Mice
(39)
Medical Sciences
(38)
Rats, Sprague-Dawley
(37)
Piperidines - Pharmacology
(35)
Pharmacology. Drug Treatments
(30)
Neuropharmacology
(29)
Psychology. Psychoanalysis. Psychiatry
(28)
Humans
(23)
Pyrazoles - Pharmacology
(23)
Fundamental And Applied Biological Sciences. Psychology
(22)
Psychiatry
(21)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

Anxiolytic- and Antidepressant-like Effects of the Non-Peptide Vasopressin V1b Receptor Antagonist, SSR149415, Suggest an Innovative Approach for the Treatment of Stress-Related Disorders

Cannabinoids Modulate Synaptic Strength and Plasticity at Glutamatergic Synapses of Rat Prefrontal Cortex Pyramidal Neurons

Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells

Nicotine-Associated Cues Maintain Nicotine-Seeking Behavior in Rats Several Weeks after Nicotine Withdrawal: Reversal by the Cannabinoid (CB ) Receptor Antagonist, Rimonabant (SR141716)

SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair

Rimonabant reduces obesity‐associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance

Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice

Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells

Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress-related disorders

Biochemical and Pharmacological Profile of a Potent and Selective Nonpeptide Antagonist of the Neurotensin Receptor

The Striatal Neurotensin Receptor Modulates Striatal and Pallidal Glutamate and GABA Release: Functional Evidence for a Pallidal Glutamate-GABA Interaction via the Pallidal-Subthalamic Nucleus Loop

Facilitation by Endogenous Tachykinins of the NMDA-Evoked Release of Acetylcholine after Acute and Chronic Suppression of Dopaminergic Transmission in the Matrix of the Rat Striatum

Neurochemical, Electrophysiological and Pharmacological Profiles of the Selective Inhibitor of the Glycine Transporter-1 SSR504734, a Potential New Type of Antipsychotic

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors

Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia

Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-I SSR504734, a potential new type of antipsychotic

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

Blockade by the cannabinoid CBI receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior

Reconciling the role of central serotonin neurons in human and animal behavior

Characterization of the profile of neurokinin-2 and neurotensin receptor antagonists in the mouse defense test battery

In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist

Specific involvement of neurotensin type 1 receptor in the neurotensin‐mediated in vivo dopamine efflux using knock‐out mice

EFFECTS OF CB1 CANNABINOID RECEPTOR BLOCKADE ON ETHANOL PREFERENCE AFTER CHRONIC ALCOHOL ADMINISTRATION COMBINED WITH REPEATED RE-EXPOSURES AND WITHDRAWALS

Suchergebnisse filtern